Cilostazol and Edaravone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cilostazol (cilostazol) and Edaravone (edaravone). Common drug interactions include drug ineffective among females and cerebral infarction among males.
The phase IV clinical study analyzes what interactions people have when they take Cilostazol and Edaravone. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Cilostazol?
Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.
What is Edaravone?
Edaravone has active ingredients of edaravone. eHealthMe is studying from 695 Edaravone users. Check the latest studies of Edaravone.
19 people who take Cilostazol and Edaravone together, and have interactions are studied.

What are the common drug interactions of Cilostazol and Edaravone, by gender? *:
female:
- Drug ineffective
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
male:
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Constipation
- Depressed level of consciousness
- Dyslalia (inability to articulate comprehensible speech)
- Hyperkalaemia (damage to or disease of the kidney)
- Infusion site extravasation (flow of (blood or lymph) from infusion site)
- Injection site pain
- Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations)
- Pyrexia (fever)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
What are the common drug interactions of Cilostazol and Edaravone, by age (0-1 to 60+)? *:
0-1:
- Drug ineffective
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Cerebral infarction (less blood supply to brain resulting tissue damage)
60+:
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Constipation
- Altered state of consciousness (altered state of mind)
- Depressed level of consciousness
- Dyslalia (inability to articulate comprehensible speech)
- Hyperkalaemia (damage to or disease of the kidney)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations)
- Pyrexia (fever)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
What are the existing conditions these people have? *
- Cerebral Infarction (less blood supply to brain resulting tissue damage): 8 people, 42.11%
- Asthma: 4 people, 21.05%
- Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 4 people, 21.05%
- Gastric Ulcer (stomach ulcer): 3 people, 15.79%
- Prostate Cancer: 3 people, 15.79%
- Lacunar Infarction (a type of stroke): 3 people, 15.79%
- Indigestion: 3 people, 15.79%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 15.79%
- Gastritis - Chronic (long lasting inflammation of stomach): 3 people, 15.79%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Cilostazol and Edaravone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cilostazol (7,877 reports)
- Edaravone (695 reports)
Browse all drug interactions of Cilostazol and Edaravone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cilostazol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Edaravone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cilostazol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Edaravone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cilostazol and edaravone (the active ingredients of Cilostazol and Edaravone, respectively), and Cilostazol and Edaravone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Adcirca cause Liver Disorder? - 4 seconds ago
- Could Fosrenol cause Gangrene? - 6 seconds ago
- Ovarian Cancer Stage Iii and Abdominal Discomfort - 9 seconds ago
- Cozaar vs. Furosemide, side effect and effectiveness comparison - 10 seconds ago
- Drug interactions of Advair Diskus 100/50 and Novolog - 10 seconds ago
- Oedema and High Blood Pressure - 11 seconds ago
- Dermatitis and Pneumonia - 11 seconds ago
- Drug interactions of Imodium Multi-Symptom Relief and Tacrolimus - 14 seconds ago
- Could Minocycline cause Abdominal Discomfort? - 17 seconds ago
- Carcinoid Syndrome and Abdominal Discomfort - 17 seconds ago